Canadian Respiratory Journal

Canadian Respiratory Journal / 2013 / Article

Focused Review | Open Access

Volume 20 |Article ID 506383 | https://doi.org/10.1155/2013/506383

George Rakovich, Lise Tremblay, "Tailored Therapy in Lung Cancer", Canadian Respiratory Journal, vol. 20, Article ID 506383, 2 pages, 2013. https://doi.org/10.1155/2013/506383

Tailored Therapy in Lung Cancer

Abstract

Historically, all non-small cell lung cancers were essentially grouped together and considered to be a single disease. However, it is now recognized that non-small cell lung cancer actually comprises a genetically diverse group of tumours. This, in turn, affords a new opportunity for the development of effective treatments tailored to individual tumours and patients. Advances in molecular biology have made possible the development of drugs against specific molecular targets on cancer cells, most notably the tyrosine kinase inhibitors. The relevant literature and current practice guidelines are discussed. In addition, other related areas of active investigation, including tumour vaccines and pharmacogenetics, are briefly reviewed.

Copyright © 2013 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views222
Downloads262
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.